Biorasis

Biorasis is a medical technology company specializing in the development of miniature, wireless, and fully implantable biosensors for continuous health monitoring. Its flagship product, the Glucowizzard, is a long-term implantable glucose sensor designed to provide real-time data for patients with diabetes without the need for frequent external sensor replacements. The company's technology integrates advanced microelectronics with proprietary biocompatible coatings to overcome the foreign body response typically associated with implants. Biorasis aims to revolutionize metabolic disease management through its highly accurate and minimally invasive sensing platform. Founded as a spin-off from the University of Connecticut, the company has received significant funding from the NIH and NSF to advance its sensor technology.